16.27
0.12%
-0.005
Acadia Pharmaceuticals Inc (ACAD) 財務データ
損益計算書
四半期ごと
*すべての数値は百万単位です
期間終了日 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
期間の長さ | 3 か月 | 3 か月 | 3 か月 | 3 か月 | 3 か月 |
Revenues |
10.91%
205.83
|
231.04 | 211.70 | 165.24 | 118.46 |
Cost Of Revenue |
28.29%
22.95
|
17.89 | 14.62 | 7.459 | 1.667 |
Gross Profit |
14.20%
182.88
|
213.15 | 197.08 | 157.78 | 116.80 |
Operating Expenses
|
5.91%
167.67
|
178.21 | 254.85 | 154.74 | 170.38 |
Benefits Costs and Expenses |
184.83
|
- | - | - | - |
Costs And Expenses |
190.62
|
- | 269.48 | 162.20 | 172.05 |
Operating Income/Loss |
56.47%
15.21
|
34.94 | -57.78 | 3.037 | -53.58 |
Income/Loss From Continuing Operations Before Tax |
90.91%
21.00
|
231.04 | -52.14 | 6.343 | -44.94 |
Income Tax Expense/Benefit |
172.97%
4.447
|
-6.094 | 13.03 | 5.229 | -1.918 |
Income/Loss From Continuing Operations After Tax |
63.85%
16.55
|
45.80 | -65.18 | 1.114 | -43.02 |
Net Income/Loss
|
63.85%
16.55
|
45.80 | -65.18 | 1.114 | -43.02 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
49.79M%
164.80
|
0.000331 | 0.1642 | 0.1635 | 162.26 |
Diluted Average Shares |
50.34M%
166.62
|
0.000331 | 0.1642 | 0.165 | 162.26 |
Basic Earnings Per Share |
64.29%
0.10
|
0.28 | -0.40 | 0.01 | -0.27 |
Diluted Earnings Per Share |
64.29%
0.10
|
0.28 | -0.40 | 0.01 | -0.27 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
大文字化:
|
ボリューム (24 時間):